Rocket


News + Filings
Transactions



Gibson Neil W

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
06/01/2023TCR2 THERAPEUTICS INC.TCRRDispositionStock Option (Right to Buy)8.1k$6.07$49k 06/01/2023
06/01/2023TCR2 THERAPEUTICS INC.TCRRDispositionStock Option (Right to Buy)12.1k$5.21$63k 06/01/2023
06/01/2023TCR2 THERAPEUTICS INC.TCRRDispositionStock Option (Right to Buy)12.1k$31.83$385.1k 06/01/2023
06/01/2023TCR2 THERAPEUTICS INC.TCRRDispositionStock Option (Right to Buy)5k$16.10$80.5k 06/01/2023
06/01/2023TCR2 THERAPEUTICS INC.TCRRDispositionStock Option (Right to Buy)6.3k$16.11$101k 06/01/2023
06/01/2023TCR2 THERAPEUTICS INC.TCRRDispositionStock Option (Right to Buy)16.8k$0.97$16.3k 06/01/2023
05/26/2023Shattuck Labs, Inc.STTKGrantStock Option (Right to Buy)40.3k$2.72$109.5k 05/26/2023
06/08/2022Shattuck Labs, Inc.STTKGrantStock Option (Right to Buy)40.3k$4.32$173.9k 06/08/2022
05/20/2022Instil Bio, Inc.TILGrantEmployee Stock Option (right to buy)30k$7.27$218.1k 05/20/2022
12/09/2021TCR2 THERAPEUTICS INC.TCRRGrantStock Option (Right to Buy)12.1k$5.21$63k 12/09/2021
12/09/2021TCR2 THERAPEUTICS INC.TCRRGrantStock Option (Right to Buy)16.8k$0.97$16.3k 12/15/2022
06/19/2021Shattuck Labs, Inc.STTKGrantStock Option (Right to Buy)3.4k$29.34$100.8k 06/19/2021
03/18/2021Instil Bio, Inc.TILGrantStock Option (right to buy)52k$20.00$1M 03/18/2021
12/22/2020Shattuck Labs, Inc.STTKGrantStock Option (Right to Buy)1.3k$53.02$68.2k 12/22/2020
12/10/2020TCR2 THERAPEUTICS INC.TCRRGrantStock Option (Right to Buy)12.1k$31.83$385.1k 12/10/2020
03/20/2020TCR2 THERAPEUTICS INC.TCRRSaleCommon Stock648$7.94$5.1ksee footnote (2)11/07/2019
03/19/2020TCR2 THERAPEUTICS INC.TCRRSaleCommon Stock3.1k$7.41$23.3ksee footnote (2)11/07/2019
03/18/2020TCR2 THERAPEUTICS INC.TCRRSaleCommon Stock3.1k$6.83$21.3ksee footnote (2)11/07/2019
03/17/2020TCR2 THERAPEUTICS INC.TCRRSaleCommon Stock3k$6.49$19.5ksee footnote (2)11/07/2019
03/16/2020TCR2 THERAPEUTICS INC.TCRRSaleCommon Stock17.7k$6.60$117ksee footnote (2)11/07/2019
03/13/2020TCR2 THERAPEUTICS INC.TCRRSaleCommon Stock52k$6.52$338.9ksee footnote (2)11/07/2019
12/19/2019TCR2 THERAPEUTICS INC.TCRRGrantStock Option (Right to Buy)5k$16.10$80.5k 12/19/2019
11/15/2019TCR2 THERAPEUTICS INC.TCRROther (disposition)Common Stock218k$0.00$0see footnote (2)11/07/2019
11/13/2019TCR2 THERAPEUTICS INC.TCRROther (disposition)Common Stock196.2k$0.00$0see footnote (2)11/07/2019
11/07/2019TCR2 THERAPEUTICS INC.TCRROther (disposition)Common Stock212.6k$0.00$0see footnote (2)11/07/2019
04/11/2019TCR2 THERAPEUTICS INC.TCRRGrantStock Option (Right to Buy)6.3k$16.11$101k 04/11/2019
02/19/2019TCR2 THERAPEUTICS INC.TCRRConversionCommon Stock706.4k$0.00$0See Footnote02/19/2019
02/19/2019TCR2 THERAPEUTICS INC.TCRRConversionSeries B Preferred Stock4.4M$0.00$0See Footnote02/19/2019
01/28/2015Regulus Therapeutics Inc.RGLSSaleCommon Stock71.3k$17.98$1.3M 01/28/2015
01/28/2015Regulus Therapeutics Inc.RGLSSaleCommon Stock8.7k$18.66$161.5k 01/28/2015
12/02/2014Regulus Therapeutics Inc.RGLSGrantStock Option (Right to Buy)90.4k$17.76$1.6M 12/02/2014
11/28/2014Regulus Therapeutics Inc.RGLSSaleCommon Stock1000$18.80$18.8k 11/28/2014
11/28/2014Regulus Therapeutics Inc.RGLSSaleCommon Stock1.5k$19.63$29.4k 11/28/2014
11/28/2014Regulus Therapeutics Inc.RGLSExerciseStock Option (Right to Buy)2.5k$1.74$4.4k 11/28/2014
10/29/2014Regulus Therapeutics Inc.RGLSSaleCommon Stock1.1k$18.68$20.5k 10/29/2014
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy